Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)

SHE:002262 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	22,508	24,744	27,326	24,736	15,769	16,092
Market Cap Growth	0.49%	-9.45%	10.47%	56.87%	-2.01%	35.74%
Enterprise Value	18,547	20,984	23,972	21,956	13,322	13,929
Last Close Price	22.15	24.35	26.77	24.06	15.09	15.31
PE Ratio	18.93	21.64	26.35	27.46	19.77	22.08
Forward PE	15.17	18.59	22.41	24.31	17.58	18.30
PS Ratio	3.85	4.34	5.42	5.76	4.01	4.79
PB Ratio	2.96	3.40	4.26	4.43	3.22	3.92
P/TBV Ratio	3.04	3.50	4.38	4.49	3.27	4.00
P/FCF Ratio	41.44	53.09	43.08	46.39	31.86	16.43
P/OCF Ratio	22.47	27.01	27.10	28.73	22.49	12.89
PEG Ratio	0.89	1.13	1.13	1.13	1.13	1.13
EV/Sales Ratio	3.17	3.68	4.76	5.11	3.39	4.14
EV/EBITDA Ratio	13.04	15.38	19.90	21.43	13.88	15.86
EV/EBIT Ratio	15.00	17.30	22.41	24.35	15.72	17.82
EV/FCF Ratio	34.15	45.02	37.79	41.17	26.91	14.22
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.02	0.01
Debt / EBITDA Ratio	0.04	0.05	0.09	0.09	0.11	0.04
Debt / FCF Ratio	0.11	0.15	0.18	0.17	0.22	0.04
Asset Turnover	0.71	0.72	0.73	0.71	0.75	0.75
Inventory Turnover	2.46	2.40	2.09	1.57	1.80	2.16
Quick Ratio	4.88	5.00	5.64	4.88	5.01	4.99
Current Ratio	5.50	5.68	6.46	5.86	5.93	5.77
Return on Equity (ROE)	16.50%	16.67%	17.25%	16.78%	17.72%	18.86%
Return on Assets (ROA)	9.39%	9.62%	9.68%	9.25%	10.14%	10.91%
Return on Capital (ROIC)	10.70%	10.94%	10.96%	10.54%	11.56%	12.55%
Return on Capital Employed (ROCE)	16.10%	16.50%	16.40%	15.90%	16.90%	18.70%
Earnings Yield	5.24%	4.62%	3.79%	3.64%	5.06%	4.53%
FCF Yield	2.41%	1.88%	2.32%	2.16%	3.14%	6.09%
Dividend Yield	1.61%	1.48%	1.20%	0.83%	1.32%	0.65%
Payout Ratio	27.40%	28.31%	19.54%	22.51%	12.63%	13.98%
Buyback Yield / Dilution	0.70%	-0.53%	0.53%	-0.22%	0.24%	-0.72%
Total Shareholder Return	2.30%	0.95%	1.72%	0.61%	1.56%	-0.07%

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.